Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis
Clinical trial NCT03047135 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03047135
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-01
- Primary completion
- 2023-05-24
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.